Robert J. Applegate, MD

Hurry, It’s a STEMI! But How Quick is Too Quick for Safety?

07/31/2013

David R. Holmes Jr., MD;

E. Magnus Ohman , MD;

Barry F. Uretsky , MD;

Peter B. Berger , MD;

Eric Bates ;

Gregg W. Stone , MD, FACC, FSCAI;

Robert J. Applegate , MD;

Sunil V. Rao , MD, FACC, FSCAI;

Ted Feldman , MD, FSCAI, FACC, FESC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Christopher J. White , DO, MD;

I asked my expert cath lab colleagues to weigh in on this issue with 3 quick answers on whether forced reduction of D2B time is 1) beneficial for the patient or 2) the hospital or 3) the interventionalist, and if you have time, a short...

I asked my expert cath lab...

07/31/2013

Cath Lab Digest

Original Contribution

The Angio-Seal Evolution Registry: Outcomes of a Novel Automated Angio-Seal Vascular Closure Device

09/09/2010

David M. Shavelle , MD, FACC, FSCAI;

Zoltan G. Turi , MD;

Robert J. Applegate , MD;

Timothy Shapiro , MD;

Naveen Sachdev , MD;

Abdel Ahmed , MD;

Arthur Szyniszewski , MD;

Antonis Pratsos , MD;

Malcom T. Foster , MD;

Steven J. Yakubov , MD;

NULL

09/09/2010

Journal of Invasive Cardiology

Commentary

Bivalirudin and DES: A PCI Strategy that Pays

08/01/2008

Robert J. Applegate , MD;

The choice of anticoagulant in patients undergoing percutaneous coronary intervention (PCI) has been the subject of intense investigation over the past decade. Ever since anticoagulation with heparin was observed to be an essential treatment...

The choice of anticoagulant in...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

On Teaching Cardiac Cath Part II: Where is Your Attending?

12/05/2014

Lloyd W. Klein , MD;

Robert J. Applegate , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Alan C. Yeung , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Molly Szerlip , MD, FACP;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Mitchell W. Krucoff , MD;

Michael Ragosta , MD;

John W. Hirshfeld Jr.;

David J. Cohen , MD, MPH, MSc;

Kirk N. Garrett ;

Barry F. Uretsky , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

George W. Vetrovec , MD;

Andrew Doorey ;

Do people think it's okay for the attending to be outside in the monitor area, intermittently engaged in other activities while trainees do cases?

Do people think it's okay for...

12/05/2014

Cath Lab Digest

Commentary

Primary PCI for STEMI ‚Äî Pushing the Limits

12/04/2009

Robert J. Applegate , MD;

The optimal management of patients with ST-elevation myocardial infarction (STEMI) has been the subject of ongoing clinical investigations for the past several decades. When it became apparent that primary angioplasty was not only feasible,...

The optimal management of...

12/04/2009

Journal of Invasive Cardiology

Commentary

Allen`s Testing Prior to Transradial Cardiac Catheterization: State of the Arch

09/02/2015

Robert J. Applegate , MD;

Rahul P. Sharma , MD, MBBS, FRACP;

Many experts recommend assessing the patency of the palmar arch prior to transradial angioplasty for cardiac catheterization; however, there are no robust data to support this practice. Therefore, it is perhaps time to reevaluate this...

Many experts recommend assessing...

09/02/2015

Journal of Invasive Cardiology

Commentary

Unintended Consequences of Femoral Artery Closure Devices

08/06/2010

Robert J. Applegate , MD;

J INVASIVE CARDIOL 2010;22:358–359 ____________________________________________________________ Vascular closure devices (VCDs) were developed in the mid-1990s to provide more effective hemostasis for femoral artery access sites, largely...

J INVASIVE CARDIOL...

08/06/2010

Journal of Invasive Cardiology

Clinical Editor's Corner

Boomer to Zoomer – Transforming to the Post-Pandemic World

07/06/2020

Barry F. Uretsky , MD;

Stephen R. Ramee , MD;

Peter C. Block , MD;

Frederic S. Resnic , MD, MSc;

Lloyd W. Klein , MD;

E. Magnus Ohman , MD;

Robert J. Applegate , MD;

Samuel M. Butman , MD;

Michael A. Kutcher , MD, FACC, FSCAI;

Jeffrey Marshall ;

Gary S. Mintz , MD;

Jonathan M. Tobis , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Chet Rihal ;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Carl L. Tommaso , MD;

Michael J. Lim , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

Christopher J. White , DO, MD;

Kirk N. Garratt , MD, MSc;

Jim Blankenship , MD;

Like many of my contemporaries, I am a boomer (aka baby boomer), a member of the post World War II generation. I grew up in the 1950-60s, graduated college in the Vietnam War era (1960-70s), and had a millennial-generation (1980-90s)...

Like many of my contemporaries,...

07/06/2020

Cath Lab Digest

Commentary

Risk Scoring Systems for PCI: Does One Size Fit All?

01/27/2011

Holly L. Humphrey , MD;

Robert J. Applegate , MD;

Predicting outcomes in patients undergoing coronary revascularization has been a topic of long-standing interest. The ACC/AHA (American College of Cardiology/American Heart Association) lesion classification system devised in 1986 and revised...

Predicting outcomes in patients...

01/27/2011

Journal of Invasive Cardiology

Clinical Editor's Corner

TAVR: Who Should Prep the Device? The Role of Industry Representatives’ Participation in the Cath Lab

01/03/2022

Christopher J. White , DO, MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Michael Ragosta , MD;

David J. Cohen , MD, MPH, MSc;

Ramon Quesada , MD, FACP, FACC, FSCAI;

Susheel K. Kodali , MD;

Stephen R. Ramee , MD;

Samuel M. Butman , MD;

Amir Kaki , MD, FACC, FSCAI;

Duane S. Pinto , MD, MPH;

William F. Fearon , MD;

Mauricio G. Cohen , MD, FACC;

Robert J. Applegate , MD;

Aaron V. Kaplan ;

David G. Rizik , MD, FACC, FSCAI;

Jeffrey Marshall ;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

After years of having the industry clinical support staff prep the transcatheter aortic valve replacement (TAVR) valves in the lab (without a single adverse event because of faulty prep, to my knowledge) some administrators have now begun to...

After years of having the...

01/03/2022

Cath Lab Digest